2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Cynthia M. Tracy; Andrew E. Epstein; Dawood Darbar; John P. DiMarco; Sandra B. Dunbar; N.A. Mark Estes; T. Bruce Ferguson; Stephen C. Hammill; Pamela E. Karasik; Mark S. Link; Joseph E. Marine; Mark H. Schoenfeld; Amit J. Shanker; Michael J. Silka; Lynne Warner Stevenson; William G. Stevenson; Paul D. Varosy

doi:10.1016/j.hrthm.2012.08.021

News from the Heart Rhythm Society Practice guideline| Volume 9, ISSUE 10, P1737-1753, October 2012

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Cynthia M. Tracy, MD, FACC, FAHA
Cynthia M. Tracy
Search for articles by this author
Andrew E. Epstein, MD, FACC, FAHA, FHRS ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
Andrew E. Epstein
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
Search for articles by this author
Dawood Darbar, MD, FACC, FHRS ^†
Author Footnotes
† ACCF/AHA Representative.
Dawood Darbar
Footnotes
† ACCF/AHA Representative.
Search for articles by this author
John P. DiMarco, MD, PhD, FACC, FHRS ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
^,^‡
Author Footnotes
‡ Heart Rhythm Society Representative.
John P. DiMarco
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
‡ Heart Rhythm Society Representative.
Search for articles by this author
Sandra B. Dunbar, RN, DSN, FAAN, FAHA ^†
Author Footnotes
† ACCF/AHA Representative.
Sandra B. Dunbar
Footnotes
† ACCF/AHA Representative.
Search for articles by this author
N.A. Mark Estes III, MD, FACC, FAHA, FHRS ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
^,^§
Author Footnotes
§ ACCF/AHA Task Force on Performance Measures Liaison.
N.A. Mark Estes III
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
§ ACCF/AHA Task Force on Performance Measures Liaison.
Search for articles by this author
T. Bruce Ferguson Jr, MD, FACC, FAHA ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
^,^∥
Author Footnotes
∥ American Association for Thoracic Surgery Representative.
^,^¶
Author Footnotes
¶ Society of Thoracic Surgeons Representative.
T. Bruce Ferguson Jr
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
∥ American Association for Thoracic Surgery Representative.
¶ Society of Thoracic Surgeons Representative.
Search for articles by this author
Stephen C. Hammill, MD, FACC, FHRS ^‡
Author Footnotes
‡ Heart Rhythm Society Representative.
Stephen C. Hammill
Footnotes
‡ Heart Rhythm Society Representative.
Search for articles by this author
Pamela E. Karasik, MD, FACC, FHRS ^†
Author Footnotes
† ACCF/AHA Representative.
Pamela E. Karasik
Footnotes
† ACCF/AHA Representative.
Search for articles by this author
Mark S. Link, MD, FACC, FHRS ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
^,^†
Author Footnotes
† ACCF/AHA Representative.
Mark S. Link
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
† ACCF/AHA Representative.
Search for articles by this author
Joseph E. Marine, MD, FACC, FHRS ^†
Author Footnotes
† ACCF/AHA Representative.
Joseph E. Marine
Footnotes
† ACCF/AHA Representative.
Search for articles by this author
Mark H. Schoenfeld, MD, FACC, FAHA, FHRS ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
^,^†
Author Footnotes
† ACCF/AHA Representative.
Mark H. Schoenfeld
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
† ACCF/AHA Representative.
Search for articles by this author
Amit J. Shanker, MD, FACC, FHRS ^‡
Author Footnotes
‡ Heart Rhythm Society Representative.
Amit J. Shanker
Footnotes
‡ Heart Rhythm Society Representative.
Search for articles by this author
Michael J. Silka, MD, FACC ^†
Author Footnotes
† ACCF/AHA Representative.
Michael J. Silka
Footnotes
† ACCF/AHA Representative.
Search for articles by this author
Lynne Warner Stevenson, MD, FACC ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
^,^#
Author Footnotes
# Heart Failure Society of America Representative.
Lynne Warner Stevenson
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
# Heart Failure Society of America Representative.
Search for articles by this author
William G. Stevenson, MD, FACC, FAHA, FHRS ^⁎
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
^,^⁎⁎
Author Footnotes
⁎⁎ ACCF/AHA Task Force on Practice Guidelines Liaison.
William G. Stevenson
Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
⁎⁎ ACCF/AHA Task Force on Practice Guidelines Liaison.
Search for articles by this author
Paul D. Varosy, MD, FACC, FHRS ^†
Author Footnotes
† ACCF/AHA Representative.
Paul D. Varosy
Footnotes
† ACCF/AHA Representative.
Search for articles by this author
Show footnotesHide footnotes
Author Footnotes
⁎ Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.
† ACCF/AHA Representative.
‡ Heart Rhythm Society Representative.
§ ACCF/AHA Task Force on Performance Measures Liaison.
∥ American Association for Thoracic Surgery Representative.
¶ Society of Thoracic Surgeons Representative.
# Heart Failure Society of America Representative.
⁎⁎ ACCF/AHA Task Force on Practice Guidelines Liaison.

Published:September 13, 2012DOI:https://doi.org/10.1016/j.hrthm.2012.08.021

Andrew E. Epstein, MD, FACC, FAHA, FHRS, Chair; John P. DiMarco, MD, PhD, FACC, FHRS; Kenneth A. Ellenbogen, MD, FACC, FAHA, FHRS; N.A. Mark Estes III, MD, FACC, FAHA, FHRS; Roger A. Freedman, MD, FACC, FHRS; Leonard S. Gettes, MD, FACC, FAHA; A. Marc Gillinov, MD, FACC, FAHA; Gabriel Gregoratos, MD, FACC, FAHA; Stephen C. Hammill, MD, FACC, FHRS; David L. Hayes, MD, FACC, FAHA, FHRS; Mark A. Hlatky, MD, FACC, FAHA; L. Kristin Newby, MD, FACC, FAHA; Richard L. Page, MD, FACC, FAHA, FHRS; Mark H. Schoenfeld, MD, FACC, FAHA, FHRS; Michael J. Silka, MD, FACC; Lynne Warner Stevenson, MD, FACC; Michael O. Sweeney, MD, FACC

Keywords

To read this article in full you will need to make a payment

Purchase one-time access:

One-time access price info

For academic or personal research use, select 'Academic and Personal'
For corporate R&D use, select 'Corporate R&D Professionals'

Subscribe:

Already a print subscriber? Claim online access

Already an online subscriber? Sign in

Register: Create an account

Institutional Access: Sign in to ScienceDirect

References

- ACCF/AHA Task Force on Practice Guidelines
Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines.
(2010)
http://assets.cardiosource.com/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdf
http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/documents/downloadable/ucm_319826.pdf
(Accessed May 16, 2012)
View in Article
- Google Scholar
- Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine
Finding What Works in Health Care: Standards for Systematic Reviews.
The National Academies Press, Washington, DC2011
View in Article
- Google Scholar
- Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine
Clinical Practice Guidelines We Can Trust.
The National Academies Press, Washington, DC2011
View in Article
- Google Scholar
- Epstein A.E.
- DiMarco J.P.
- Ellenbogen K.A.
- et al.
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices).
J Am Coll Cardiol. 2008; 51: e1-e62
View in Article
- Gersh B.J.
- Maron B.J.
- Bonow R.O.
- et al.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol. 2011; 58: e212-e260
View in Article
- Ackerman M.J.
- Priori S.G.
- Willems S.
- et al.
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies.
Heart Rhythm. 2011; 8: 1308-1339
View in Article
- Horner J.M.
- Kinoshita M.
- Webster T.L.
- et al.
Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience.
Heart Rhythm. 2010; 7: 1616-1622
View in Article
- Schwartz P.J.
- Spazzolini C.
- Priori S.G.
- et al.
Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?.
Circulation. 2010; 122: 1272-1282
View in Article
- Berul C.I.
- Van Hare G.F.
- Kertesz N.J.
- et al.
Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
J Am Coll Cardiol. 2008; 51: 1685-1691
View in Article
- Barsheshet A.
- Wang P.J.
- Moss A.J.
- et al.
Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy).
J Am Coll Cardiol. 2011; 57: 2416-2423
View in Article
- Silka M.J.
- Bar-Cohen Y.
Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?.
Circ Arrhythm Electrophysiol. 2008; 1: 298-306
View in Article
- Khairy P.
- Harris L.
- Landzberg M.J.
- et al.
Implantable cardioverter-defibrillators in tetralogy of Fallot.
Circulation. 2008; 117: 363-370
View in Article
- van der Hulst A.E.
- Delgado V.
- Blom N.A.
- et al.
Cardiac resynchronization therapy in paediatric and congenital heart disease patients.
Eur Heart J. 2011; 32: 2236-2246
View in Article
- Lampert R.
- Hayes D.L.
- Annas G.J.
- et al.
HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.
Heart Rhythm. 2010; 7: 1008-1026
View in Article
- Wilkoff B.L.
- Auricchio A.
- Brugada J.
- et al.
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations.
Heart Rhythm. 2008; 5: 907-925
View in Article
- Abraham W.T.
- Fisher W.G.
- Smith A.L.
- et al.
Cardiac resynchronization in chronic heart failure.
N Engl J Med. 2002; 346: 1845-1853
View in Article
- Bristow M.R.
- Saxon L.A.
- Boehmer J.
- et al.
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
N Engl J Med. 2004; 350: 2140-2150
View in Article
- Cleland J.G.F.
- Daubert J.-C.
- Erdmann E.
- et al.
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med. 2005; 352: 1539-1549
View in Article
- Hunt S.A.
- Abraham W.T.
- Chin M.H.
- et al.
2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation. 2009; 119: e391-e479
View in Article
- Moss A.J.
- Hall W.J.
- Cannom D.S.
- et al.
Cardiac-resynchronization therapy for the prevention of heart-failure events.
N Engl J Med. 2009; 361: 1329-1338
View in Article
- Tang A.S.L.
- Wells G.A.
- Talajic M.
- et al.
Cardiac-resynchronization therapy for mild-to-moderate heart failure.
N Engl J Med. 2010; 363: 2385-2395
View in Article
- Linde C.
- Abraham W.T.
- Gold M.R.
- et al.
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
J Am Coll Cardiol. 2008; 52: 1834-1843
View in Article
- Brignole M.
- Gammage M.
- Puggioni E.
- et al.
Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation.
Eur Heart J. 2005; 26: 712-722
View in Article
- Brignole M.
- Botto G.
- Mont L.
- et al.
Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
Eur Heart J. 2011; 32: 2420-2429
View in Article
- Doshi R.N.
- Daoud E.G.
- Fellows C.
- et al.
Left ventricular–based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).
J Cardiovasc Electrophysiol. 2005; 16: 1160-1165
View in Article
- Gasparini M.
- Auricchio A.
- Regoli F.
- et al.
Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
J Am Coll Cardiol. 2006; 48: 734-743
View in Article
- Wilton S.B.
- Leung A.A.
- Ghali W.A.
- et al.
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis.
Heart Rhythm. 2011; 8: 1088-1094
View in Article
- Wilkoff B.L.
- Cook J.R.
- Epstein A.E.
- et al.
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
JAMA. 2002; 288: 3115-3123
View in Article
- Adelstein E.
- Schwartzman D.
- Gorcsan 3rd, J.
- Saba S.
Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization.
J Cardiovasc Electrophysiol. 2011; 22: 905-911
View in Article
- Vatankulu M.A.
- Goktekin O.
- Kaya M.G.
- et al.
Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
Am J Cardiol. 2009; 103: 1280-1284
View in Article
- Rickard J.
- Bassiouny M.
- Cronin E.M.
- et al.
Predictors of response to cardiac resynchronization therapy in patients with a non–left bundle branch block morphology.
Am J Cardiol. 2011; 108: 1576-1580
View in Article
- Masci P.G.
- Marinelli M.
- Piacenti M.
- et al.
Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study.
Circ Cardiovasc Imaging. 2010; 3: 482-490
View in Article
- Kashani A.
- Barold S.S.
Significance of QRS complex duration in patients with heart failure.
J Am Coll Cardiol. 2005; 46: 2183-2192
View in Article
- Doval H.C.
- Nul D.R.
- Grancelli H.O.
- et al.
Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).
Lancet. 1994; 344: 493-498
View in Article
- Bleeker G.B.
- Schalij M.J.
- Molhoek S.G.
- et al.
Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure.
J Cardiovasc Electrophysiol. 2004; 15: 544-549
View in Article
- Blanc J.J.
- Etienne Y.
- Gilard M.
- et al.
Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study.
Circulation. 1997; 96: 3273-3277
View in Article
- Prinzen F.W.
- Vernooy K.
- De Boeck B.W.L.
- et al.
Mechano-energetics of the asynchronous and resynchronized heart.
Heart Fail Rev. 2011; 16: 215-224
View in Article
- Ukkonen H.
- Sundell J.
- Knuuti J.
Effects of CRT on myocardial innervation, perfusion and metabolism.
Europace. 2008; 10: iii114-iii117
View in Article
- Cazeau S.
- Leclercq C.
- Lavergne T.
- et al.
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
N Engl J Med. 2001; 344: 873-880
View in Article
- Stellbrink C.
- Breithardt O.A.
- Franke A.
- et al.
Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances.
J Am Coll Cardiol. 2001; 38: 1957-1965
View in Article
- Bradley D.J.
- Bradley E.A.
- Baughman K.L.
- et al.
Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials.
JAMA. 2003; 289: 730-740
View in Article
- Haghjoo M.
- Bagherzadeh A.
- Fazelifar A.F.
- et al.
Prevalence of mechanical dyssynchrony in heart failure patients with different QRS durations.
Pacing Clin Electrophysiol. 2007; 30: 616-622
View in Article
- Stavrakis S.
- Lazzara R.
- Thadani U.
The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis.
J Cardiovasc Electrophysiol. 2012; 23: 163-168
View in Article
- Sipahi I.
- Carrigan T.P.
- Rowland D.Y.
- et al.
Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
Arch Intern Med. 2011; 171: 1454-1462
View in Article
- Saxon L.A.
- Ellenbogen K.A.
Resynchronization therapy for the treatment of heart failure.
Circulation. 2003; 108: 1044-1048
View in Article
- Bilchick K.C.
- Kamath S.
- DiMarco J.P.
- Stukenborg G.J.
Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients.
Circulation. 2010; 122: 2022-2030
View in Article
- Adelstein E.C.
- Saba S.
Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization.
Am J Cardiol. 2009; 103: 238-242
View in Article
- Rickard J.
- Kumbhani D.J.
- Gorodeski E.Z.
- et al.
Cardiac resynchronization therapy in non–left bundle branch block morphologies.
Pacing Clin Electrophysiol. 2010; 33: 590-595
View in Article
- Upadhyay G.A.
- Choudhry N.K.
- Auricchio A.
- et al.
Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies.
J Am Coll Cardiol. 2008; 52: 1239-1246
View in Article
- Beshai J.F.
- Grimm R.A.
- Nagueh S.F.
- et al.
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.
N Engl J Med. 2007; 357: 2461-2471
View in Article
- Ariga R.
- Tayebjee M.H.
- Benfield A.
- et al.
Greater three-dimensional ventricular lead tip separation is associated with improved outcome after cardiac resynchronization therapy.
Pacing Clin Electrophysiol. 2010; 33: 1490-1496
View in Article
- Singh J.P.
- Klein H.U.
- Huang D.T.
- et al.
Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial.
Circulation. 2011; 123: 1159-1166
View in Article
- Linde C.
- Leclercq C.
- Rex S.
- et al.
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.
J Am Coll Cardiol. 2002; 40: 111-118
View in Article
- Sweeney M.O.
- Prinzen F.W.
A new paradigm for physiologic ventricular pacing.
J Am Coll Cardiol. 2006; 47: 282-288
View in Article
- Sharma A.D.
- Rizo-Patron C.
- Hallstrom A.P.
- et al.
Percent right ventricular pacing predicts outcomes in the DAVID trial.
Heart Rhythm. 2005; 2: 830-834
View in Article
- Steinberg J.S.
- Fischer A.
- Wang P.
- et al.
The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II.
J Cardiovasc Electrophysiol. 2005; 16: 359-365
View in Article
- Lindenfeld J.
- Feldman A.M.
- Saxon L.
- et al.
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Circulation. 2007; 115: 204-212
View in Article
- Amin M.S.
- Fox A.D.
- Kalahasty G.
- et al.
Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
J Cardiovasc Electrophysiol. 2008; 19: 1275-1280
View in Article
- Abraham W.T.
- Young J.B.
- León A.R.
- et al.
Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Circulation. 2004; 110: 2864-2868
View in Article
- Daubert C.
- Gold M.R.
- Abraham W.T.
- et al.
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
J Am Coll Cardiol. 2009; 54: 1837-1846
View in Article
- Singh J.P.
- Gras D.
Biventricular pacing: current trends and future strategies.
Eur Heart J. 2012; 33: 305-313
View in Article
- Stevenson W.G.
- Hernandez A.F.
- Carson P.E.
- et al.
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.
J Card Fail. 2012; 18: 94-106
View in Article
- Dickstein K.
- Vardas P.E.
- Auricchio A.
- et al.
2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy.
Eur Heart J. 2010; 31: 2677-2687
View in Article
- Dubner S.
- Auricchio A.
- Steinberg J.S.
- et al.
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
Europace. 2012; 14: 278-293
View in Article
- Crossley G.H.
- Chen J.
- Choucair W.
- et al.
Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.
J Am Coll Cardiol. 2009; 54: 2012-2019
View in Article
- Crossley G.H.
- Boyle A.
- Vitense H.
- et al.
The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.
J Am Coll Cardiol. 2011; 57: 1181-1189
View in Article
- Varma N.
- Epstein A.E.
- Irimpen A.
- et al.
Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
Circulation. 2010; 122: 325-332
View in Article
- Mabo P.
- Victor F.
- Bazin P.
- et al.
A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial).
Eur Heart J. 2012; 33: 1105-1111
View in Article
- Saxon L.A.
- Hayes D.L.
- Gilliam F.R.
- et al.
Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study.
Circulation. 2010; 122: 2359-2367
View in Article

Article info

Publication history

Published online: September 13, 2012

Footnotes

This document was approved by the American College of Cardiology Foundation Board of Trustees, the American Heart Association Science Advisory and Coordinating Committee, and the Heart Rhythm Society Board of Trustees in May 2012.

The American College of Cardiology Foundation requests that this document be cited as follows: Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NAM 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012;60:1297–1313.

This article is copublished in Circulation, Heart Rhythm, and Journal of Thoracic and Cardiovascular Surgery.

Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource.org), the American Heart Association (my.americanheart.org), and the Heart Rhythm Society (www.hrsonline.org). For copies of this document, please contact Elsevier Inc. Reprint Department, fax (212) 633-3820, e-mail [email protected]

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please contact Elsevier's permission department at [email protected]

Developed in Collaboration With the American Association for Thoracic Surgery, Heart Failure Society of America, and Society of Thoracic Surgeons

Identification

DOI: https://doi.org/10.1016/j.hrthm.2012.08.021

Copyright

ScienceDirect

Access this article on ScienceDirect

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes